Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416154 · ClinicalTrials.gov registry record
Expression of IFN-epsilon in the Female Reproductive Tract
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 32
- Enrollment target
NCT02416154: Completed study, sponsored by University of Pittsburgh.
NCT02416154 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02416154 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The proposed study aims to determine the expression of Interferon-ε (IFNε) in the female genital tract, which has never been mapped before in humans. High expression in other mammalian female reproductive tract (FRT) has been suggested to be important in anti-sexually transmitted infection (STI)/HIV immunity and its expression decreases with progestogen treatment. Future studies are planned to understand if hormonal contraceptives affect the presence of interferon in the healthy female genital tract, potentially changing the risk of for STI and HIV.
Primary Outcome
Interferon epsilon expression will be assessed in the female reproductive tract and blood in women in the follicular phase of menses vs the luteal phase of menses in this cross-sectional study.
Interventions
- PROCEDURE Reproductive tract and blood sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-07 |
| Est. Completion | 2020-05 |
What the finished NCT02416154 record still lists
NCT02416154 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Reproductive tract and blood sampling is the first listed.
NCT02416154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02416154 about?
NCT02416154 is a clinical study titled "Expression of IFN-epsilon in the Female Reproductive Tract". The proposed study aims to determine the expression of Interferon-ε (IFNε) in the female genital tract, which has never been mapped before in humans. High expression in other mammalian female reproductive tract (FRT) has been suggested to be important in anti-sexually transmitted infection (STI)/HIV...
What is the current status of trial NCT02416154?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-07. Estimated completion is 2020-05.
What interventions are being tested in trial NCT02416154?
The interventions under investigation include: Reproductive tract and blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT02416154?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia